Interventional Cardiology Perspective

 
 
  • ECG Challenge: Smoker With Severe Chest Pain A 49-year-old man is rushed to the ED with substernal chest pain and nausea. What does his ECG reveal?
  • May 19 2023 This Week in Cardiology   When to use an ICD, risk stratification for HCM, blending EP and structural cardiology to improve care in post-TAVI patients, and hsTroponins are the topics John Mandrola, MD, discusses in this week’s podcast.
  • EuroPCR 2023 Read clinically focused news coverage of key developments from EuroPCR 2023
  • May 12 2023 This Week in Cardiology   Two new papers on left atrial appendage occlusion, the promise of DNA, statins in the elderly, and SGLT2 inhibitors are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Ablation as First-Line Treatment for AF: 5 Things to Know Ablation is a mainstay of AF treatment, but disagreement persists regarding its use as a first-line option. In comparing study outcomes, we will explore how ablation is evolving and the rationale for it becoming first-line therapy for some patients with this debilitating arrhythmia.
  • EHRA 2023 Read clinically focused news coverage of key developments from EHRA 2023
  • Apr 14 2023 This Week in Cardiology   SCAI consensus document on LAAC, semaglutide/tirzepatide disruption, NSAIDs, and interventional echocardiography are the topics discussed by John Mandrola, MD, on this week’s podcast.
  • Why Aren't Clinicians Referring Patients to Cardiac Rehab? According to Dr Cate Collings, it's even financially feasible to start a cardiac rehab program in a primary care practice.
  • Mar 10 2023 This Week in Cardiology   ACC Recap Part 1: Sports, bempedoic acid NASCARs, tricuspid regurgitation, and more on revascularization of stable CAD. are the topics discussed by John Mandrola, MD, in this week's podcast.
  • Mar 03 2023 This Week in Cardiology   Renal denervation, AF ablation, omecamtiv mecarbil, and an ACC Preview are the topics discussed by John Mandrola, MD, in this week's podcast.
  • Universal Testing for Lp(a): What Are We Waiting For? A retired cardiologist with a personal history with the atherogenic molecule calls for universal testing for lipoprotein (a).
  • Jan 20 2023 This Week in Cardiology   The loop diuretic duels, adverse events during hospital admissions, BP accuracy, and left main revascularization strategies (again) are the topics John Mandrola discusses in this week’s podcast.
  • Jan 6 2023 This Week in Cardiology   Damar Hamlin, obesity and semaglutide, Open Data and PCSK9 inhibitors, and TAVI vs SAVR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Top Cardiology Trials of 2022   Trials on heart failure, hypertension and lipid-lowering drugs, and the evolution of antithrombin and antiplatelet therapy are discussed in part 2 of cardiologists Bob Harrington and Mike Gibson's annual review.
  • Dec 16 2022 This Week in Cardiology   BP control over the long term, omecamtiv mecarbil, incentives and Goodhart’s law, and open science are the topics John Mandrola, MD, covers in this week’s podcast.
  • Mandrola’s Top 10 Cardiology Stories of 2022 A few dogmas felled, wins for meds, an exemplary trial, and clinical trends good and bad are covered in John Mandrola’s annual wrap up of cardiology stories for 2022.
  • Caring, Commitment, and Compassion in the Treatment of Heart Failure   Javed Butler, MD, considers the example of a mentor whose commitment to the care of patients provided a pattern to follow.
  • AHA 2022 Did ISCHEMIA Change the Path to Cath in Stable CAD?   Michelle O'Donoghue and interventional cardiologists Rasha Al-Lamee, and Jacqueline Tamis-Holland discuss if the ISCHEMIA trial changed the management of patients with stable coronary artery disease.
  • Nov 18 2022 This Week in Cardiology   AHA 2022, Part 2: IRONMAN, ECMO-CS, CTS-AMI, and PROGRESSIVE AF are the trials John Mandrola, MD, reviews in this week’s podcast.
  • Percutaneous LAA Closure in Patients With AF   What considerations are involved in percutaneous LAA closure in stroke risk management for patients with AF? Drs Ashish Bhimani and Sandeep Goyal examine the evidence.